论文部分内容阅读
本研究目的在于通过对北京和武汉地区细菌耐药性情况的监测,分析我们国家这些地区的细菌耐药流行学特点,为合理使用抗菌药物和做好院内感染控制工作等提供参考。本课题系同WHO合作,组织北京和武汉地区数家大医院参加监测工作;按美国NCCLS分布的标准操作方法和判断标准进行药敏测定;采用WHO/EMC提供的WHONET4软件进行数据管理和分析处理;本文包括北京地区1994～1997连续4年和武汉地区1996年的监测结果。(1)北京地区1997年7557株菌中,绿脓杆菌占16.86％,大肠杆菌占13.60％,金黄色葡萄球菌占7.94％,表皮葡萄球菌占8.11％。(2)北京地区1997年分离的菌株中,痰标本占44.2％,尿标本占
The aim of this study is to provide a reference for the rational use of antibacterials and for the control of nosocomial infections through the monitoring of the bacterial resistance in Beijing and Wuhan and the epidemiological characteristics of bacterial resistance in these countries in our country. The subject of cooperation with WHO, the organization of Beijing and Wuhan large hospitals to participate in monitoring; according to the United States NCCLS standard operating methods and criteria for drug susceptibility testing; using WHO / EMC WHONET4 software for data management and analysis This article includes the monitoring results of 1994 and 1997 in Beijing for four consecutive years and 1996 in Wuhan. (1) In 7575 strains of bacteria in Beijing area, Pseudomonas aeruginosa accounted for 16.86%, Escherichia coli accounted for 13.60%, Staphylococcus aureus accounted for 7.94% and Staphylococcus epidermidis accounted for 8.11%. (2) Among the isolates isolated in 1997 in Beijing, sputum samples accounted for 44.2% and urine samples accounted for